Recombinant multi-species DEFB126 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DEFB126 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13. The encoded protein is highly similar to an epididymal-specific secretory protein (ESP13.2) from cynomolgus monkey. Mutation of this gene is associated with impaired sperm function. [provided by RefSeq, Nov 2014]
The Alternative Names of target: 2D6glycoprotein,9230002F21Rik,Beta-defensin 126,Beta-defensin 26 (DEFB-26),C20orf8,CBD141,DEFB-26,DEFB126,DEFB26,Defb22,Defensin,Epididymal secretory protein 13.2 (ESP13.2),HBD26,bA530N10.1,beta 126,hBD-26

Target products collectionGo to DEFB126 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0152-Ag-1/ GM-Tg-hg-SE0152-Ag-2 Human DEFB126 protein Human
GM-Tg-rg-SE0152-Ag-1/ GM-Tg-rg-SE0152-Ag-2 Rat DEFB126 protein Rat
GM-Tg-mg-SE0152-Ag-1/ GM-Tg-mg-SE0152-Ag-2 Mouse DEFB126 protein Mouse
GM-Tg-cynog-SE0152-Ag-1/ GM-Tg-cynog-SE0152-Ag-2 Cynomolgus/Rhesus macaque DEFB126 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0152-Ag-1/ GM-Tg-felg-SE0152-Ag-2 Feline DEFB126 protein Feline
GM-Tg-cang-SE0152-Ag-1/ GM-Tg-cang-SE0152-Ag-2 Canine DEFB126 protein Canine
GM-Tg-bovg-SE0152-Ag-1/ GM-Tg-bovg-SE0152-Ag-2 Bovine DEFB126 protein Bovine
GM-Tg-equg-SE0152-Ag-1/ GM-Tg-equg-SE0152-Ag-2 Equine DEFB126 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0152-Ag-1/ GM-Tg-hg-SE0152-Ag-2; GM-Tg-rg-SE0152-Ag-1/ GM-Tg-rg-SE0152-Ag-2;
GM-Tg-mg-SE0152-Ag-1/ GM-Tg-mg-SE0152-Ag-2; GM-Tg-cynog-SE0152-Ag-1/ GM-Tg-cynog-SE0152-Ag-2;
GM-Tg-felg-SE0152-Ag-1/ GM-Tg-felg-SE0152-Ag-2; GM-Tg-cang-SE0152-Ag-1/ GM-Tg-cang-SE0152-Ag-2;
GM-Tg-bovg-SE0152-Ag-1/ GM-Tg-bovg-SE0152-Ag-2; GM-Tg-equg-SE0152-Ag-1/ GM-Tg-equg-SE0152-Ag-2
Products Name DEFB126 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DEFB126
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DEFB126 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.